Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro

Gene Therapy

Volumn 5, Issue 7, 1998, Pages 995-1002

  Chillon M ^a   Lee, J H ^a   Fasbender, A ^a   Welsh, M J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Adenovirus; Antibody; Cationic lipid; Gene transfer; Neutralization; Polyethylene glycol

Indexed keywords

ANTISERUM; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPID; MACROGOL; NEUTRALIZING ANTIBODY;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; FILM COATING; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES;

EID: 0031856891     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300665     Document Type: Article

References (35)

1. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995; 270: 404-410.
2. Wilson JM. Adenovirus as gene-delivery vehicles. New Engl J Med 1996; 334: 1185-1187.
3. O'Neal WK, Beaudet AL. Somatic gene therapy for cystic fibrosis. Hum Mol Genet 1994; 3: 1497-1502.
4. Kay MA et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 1994; 91: 2353-2357.
5. Jaffe HA et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet 1992; 1: 372-378.
6. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
7. Kaplan JM et al. Humoral and cellular immune responses of non-human primates to long term repeated lung exposure to Ad2/CFTR-2. Gene Therapy 1996; 3: 117-127.
8. Yei S et al. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Therapy 1994; 1: 192-200.
9. Smith TA et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 1993; 5: 397-402.
10. Wilmott RW et al. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates. Hum Gene Ther 1996; 7: 301-318.
11. Zabner J et al. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet 1994; 6: 75-83.
12. Horwitz MS. Adenoviruses. In: Fields BN, Knipe DM (eds). Fields Virology. Raven Press: New York, 1990, pp 1723-1740.
13. Wohlfart C. Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J Virol 1988; 62: 2321-2328.
14. Zabner J et al. Repeat administration of an adenovirus vector encoding CFTR to the nasal epithelium of patients with cystic fibrosis. J Clin Intest 1996; 97: 1504-1511.
15. Kay MA et al. Long-term hepatic adenovirus-mediated gene expression in mice following ctla4ig administration. Nat Genet 1995; 11: 191-197.
16. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med 1995; I: 890-893.
17. Zsengeller ZK et al. Anti-T cell receptor antibody prolongs transgene expression and reduces lung inflammation after adenovirus-mediated gene transfer. Hum Gene Ther 1997, 8: 935-941.
18. Mitani K, Graham FL, Caskey CT, Kochanek S. Rescue, propagation and partial purification of a helper virus-dependent adenovirus vector. Proc Natl Acod Sci USA 1995; 92: 3854-3858.
19. Parks RJ et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 1996; 93: 13565-13570.
20. Lieber A, He CY, Kirollova I, Kay MA. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J Virol 1996; 70: 8944-8960.
21. Fasbender A et al. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 1997; 272: 6479-6489.
22. Zalipsky S. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjug Chem 1995; 6: 150-165.
23. Inada Y et al. Modification of proteins with polyethylene glycol derivatives. Meth Enzymol 1994; 242: 65-91.
24. Torchilin VP. How do polymers prolong circulation time of liposomes? J Liposome Res 1996; 6: 99-116.
25. 1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett 1991; 284: 263-266.
26. Uster PS et al. Insertion of polyfethylene glycol) derivatized pho'spholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett 1996; 386: 243-246.
27. MacDonald RI. Membrane fusion due to dehydration by polyethylene glycol, dextran, or sucrose. Biochemistry 1985; 24: 4058-4066.
28. Ogier G et al. Inhibition of type 5 adenovirus infectivity by periodate oxidation. Arch Virol 1994; 135: 43-60.
29. Seth P, Rosenfeld M, Higginbotham J, Crystal RG. Mechanism of enhancement of DNA expression consequent to cointernalization of a replication-deficient adenovirus and unmodified plasmid DNA. J Virol 1994; 68: 933-940.
30. Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR. Integrin alpha v beta 5 selectively promotes adenovirus-mediated cell membrane permeabilization. J Cell Biol 1994; 127: 257-264.
31. Seth P. Adenovirus-dependent release of choline from plasma membrane vesicles at an acidic pH is mediated by the penton base protein. J Virol 1994; 68: 1204-1206.
32. Greber UF, Webster P, Weber J, Helenius A. The role of the adenovirus protease in virus entry into cells. EMBO J 1996; 15: 1766-1777.
33. Bachmann MF et al. The role of antibody concentration and avidity in antiviral protection. Science 1997; 276: 2024-2027
34. Van Ginkel FW et al. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA anti-bodies to adenovirus and β-galactosidase. Hum Gene Ther 1995; 6: 895-903.
35. Gahery-Segard H et al. Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts. Eur J Immunol 1997; 27: 653-659.